David Shaw’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,100
Closed -$192K 4781
2024
Q1
$192K Buy
+16,100
New +$179K ﹤0.01% 3933
2022
Q3
Sell
-58,200
Closed -$917K 5458
2022
Q2
$917K Buy
+58,200
New +$977K ﹤0.01% 3690
2018
Q4
Sell
-19,600
Closed -$335K 3942
2018
Q3
$335K Buy
19,600
+8,900
+83% +$153K ﹤0.01% 3312
2018
Q2
$193K Buy
+10,700
New +$214K ﹤0.01% 3563
2017
Q2
Sell
-41,200
Closed -$1M 3512
2017
Q1
$1M Hold
41,200
﹤0.01% 2305
2016
Q4
$1.11M Buy
+41,200
New +$1.02M ﹤0.01% 2396
2015
Q1
Sell
-10,000
Closed -$166K 3928
2014
Q4
$166K Sell
10,000
-20,000
-67% -$422K ﹤0.01% 3839
2014
Q3
$976K Sell
30,000
-40,000
-57% -$1.36M ﹤0.01% 2839
2014
Q2
$2.45M Buy
70,000
+49,200
+237% +$1.62M ﹤0.01% 2148
2014
Q1
$659K Buy
+20,800
New +$578K ﹤0.01% 3373

Other funds holding PTEN

David Shaw's PTEN Position: Q2 2026 in Review

David Shaw increased its Patterson-UTI (PTEN) stake by 361% in Q2 2026, buying an estimated $10.5M and bringing the position to 1,200,114 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #1731.

David Shaw first reported a position in PTEN in Q2 2013 and has held it in 48 quarters since. The position peaked at $41.2M in Q1 2015. 435 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • David Shaw held 1,200,114 shares of Patterson-UTI worth $11M as of Q2 2026.
  • David Shaw bought 939,611 Patterson-UTI shares in Q2 2026, an estimated $10.5M.
  • Patterson-UTI made up 0.01% of David Shaw's portfolio in Q2 2026, its #1731 holding.
  • David Shaw first reported a position in Patterson-UTI in Q2 2013 and has held it in 48 quarters since.
  • David Shaw's Patterson-UTI position peaked at $41.2M in Q1 2015.
  • 435 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.